Harpoon stock: buy or sell?

HARP stock price: $14.73 1.73% At close on February 26th, 2020

Updated on:
February 26th, 2020

0

Shares of Harpoon rose a fine 1.73% and closed at $14.73. On Feb 14th HARP plummed a chilling -7.93%.

Should I buy Harpoon stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading plan that fits your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Harpoon Therapeutics stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean HARP will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Harpoon stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for HARP stock for the last month.

Harpoon stock analysis

Daily outlook

Harpoon rose a fine 1.73% and closed at $14.73.

Shares of Harpoon Therapeutics ended today at $14.73 and rose a fine 1.73%. On February 3rd HARP price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. HARP shows a short term strength with several rising tops and rising bottoms. In the very short term, yesterday it marked a new bottom at $14.15 that should act a support if Harpoon starts a trading flat base in the range of $14.15 - $17.24 Trading the long side, we should wait to a new breakout over $17.24 to find the next buy point. Since December when SMA50d and SMA100d crossed up, HARP price slipped $-3.97 per share (-21.23%). On December, HARP hit a new all time high, pushing higher than on December tops. Check different trading setups that use ATHs as triggers.

HARP stock chart (daily)

Weekly outlook

Harpoon eased a terrifying -3.85% this week. Early February HARP climbed a dazzling 10.81% in just one week. Late January HARP collapsed a spooky -10.01% in just one week.

Harpoon Therapeutics is in a clear downtrend, marking consecutive falling peaks and bottoms. Now is trading in between the - range. There is an opportunity to rebound and reverse this situation if price can hold above the level. Not so far away is the last price record Harpoon marked late December 2019, but since then it dropped a 31.39%. Early February HARP price bounced up over the SMA of 40 weeks that acted as support stopping new slides.

HARP stock chart (weekly)

Harpoon stock price history

Harpoon stock went public on February 8th, 2019 with a price of $14.001. Since then, HARP stock surged a 5.20%, with a yearly average of 5.20%. If you had invested right after HARP's IPO a $1,000 in Harpoon stock in 2019, it would worth $52.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Harpoon stock historical price chart

HARP stock reached all-time highs on December with a price of $21.47.

Harpoon stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' HARP stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price forecast for Harpoon Therapeutics stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report on March, Harpoon Therapeutics . Unfortunately, reported EPS is not yet available in our database.
HARP earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q4-n/an/an/a
2018-Q3-n/an/an/a
2018-Q42019-03-14n/a-8.15n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to 2017, last anual sales report draw a dazzling gain of 570.90% to $4.75 million dollars. Similarly, its profit margin (compared to sales) boosted to -576.13%, that is $-27.37 million.

HARP annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2017$0.71 M-$-16.83 M-2377.1%-
2018$4.75 M570.90%$-27.37 M-576.1%62.60%

Quarterly financial results

Harpoon posted $1.06 M in revenues for 2018-Q4, a inf% up compared to previous quarter. Reported quarter income marked $-9.73 million with a profit margin of -916.29%. Profit margin remained constant a 0.00% compared to previous quarter when profit margin was nan%. When comparing sales to same quarter last year, Harpoon Therapeutics sales marked an exceptional growth and rocketed a 50.00%.
HARP quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q4$0.71 M-$-4.94 M-697.7%-
2018-Q4$1.06 M50.00%$-9.73 M-916.3%96.98%

Harpoon ownership

When you are planning to invest in shares of a stock, it's worth to have a look its ownership structure.

Harpoon Therapeutics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 29.23% of all shares.

In case of Harpoon Therapeutics stock, 76.52% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for HARP stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Harpoon:

HARP
Market cap$362.9 M
Total shares24.6 M
Float shares7.6 M
  - Institutional holdings (%)76.5%
  - Insider holdings (%)29.2%
Shares in short selling0.0%

Harpoon summary

Wednesday, February 26th, 2020
Open$14.42
Close$14.73
Day range$14.42 - $15.30
Previous close$14.48
Session gain1.73%
Average true range$1.03
50d mov avg$15.36
100d mov avg$15.01
200d mov avg$14.13
Daily patternlb03a
Weekly pattern lt02a

Harpoon performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Harpoon Therapeutics against in the following table:
Stock3m6m12m
HARPHarpoon Therapeut...-21.23%1.73%-9.07%

Harpoon competitors

Unfortunately, we could not find any public company that could be defined as Harpoon competitor. This doesn't mean Harpoon does not have any competitor in the market, it's just we could not detected it.